Skip to main content Accessibility help
×
Home

Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012

  • K. HUYGEN (a1), C. RODEGHIERO (a1), D. GOVAERTS (a2), I. LEROUX-ROELS (a3), P. MELIN (a4), M. REYNDERS (a5), S. VAN DER MEEREN (a6), S. VAN DEN WIJNGAERT (a7) and D. PIERARD (a6)...

Summary

The last report on pertussis seroprevalence in Belgium concerned samples collected during 1993–1994. In the context of the Eupert-Labnet WP6 seroprevalence study (comparing sera from 16 European member states), 1500 anonymized leftover diagnostic samples were collected randomly during the second semester of 2012 by the clinical chemistry laboratories of six participating Belgian centres, distributed equally between Flanders, Wallonia and Brussels Capital Region. As suggested by the WP6 organizers, a total of 750 samples (125/centre) were selected from subjects in the 20–29 years age group and 750 samples (125/centre) from subjects in the 30–39 years age group. Anti-PT IgG levels were measured using Virion-Serion ELISA and analysed using predefined cut-off levels. Sixty-one (4%) sera were indicative of an infection in the past 2 years (between 50 and 100 IU/ml) and another 61 (4%) sera had anti-PT IgG antibodies reflecting acute infection (>100 IU/ml). These results highlight the presence of a Bordetella pertussis reservoir in the adult ‘healthy’ Belgian population.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012
      Available formats
      ×

Copyright

Corresponding author

* Author for correspondence: Dr K. Huygen, Service Immunology, Scientific Institute of Public Health (WIV-ISP Site Ukkel), 642 Engelandstraat, B1180 Brussels, Belgium. (Email: kris.huygen@wiv-isp.be)

References

Hide All
1. Zepp, F, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infectious Diseases 2011; 11: 557570.
2. Vincent, M, et al. Pertussis serodiagnosis in Belgium from 1990 to 2009. Clinical and Vaccine Immunology 2011; 18: 588594.
3. Hallander, HO, et al. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2009; 117: 797807.
4. Van der Wielen, M, et al. Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine 2003; 21: 24122417.
5. Theeten, H, et al. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphteria and tetanus in Belgium. Epidemiology and Infection 2011; 139: 494504.
6. Olin, P, et al. Randomized controlled trial of two-component, three-component and five-component acellular pertussis vaccines compared to whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997; 350: 1569–77.
7. Hendrikx, L, et al. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 2009; 27: 65306536.
8. Wiley, K, et al. Sources of pertussis infection in young childen: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013; 31: 618625.
9. Wendelboe, AM, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infections Disease Journal 2005; 24: S58S61.
10. de Greeff, SC, et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis . PLoS ONE 2010; 5:e14183.
11. Aguas, R, Goncalves, G, Gomes, MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infectious Diseases 2006; 6: 112117.
12. DeMaria, A, Lett, SM. Vaccinate the Village. Clinical Infectious Diseases 2010; 50: 13461348.
13. Forsyth, KD, et al. Global Pertussis Initiative: new pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative. Clinical Infectious Diseases 2004; 39: 18021809.
14. Munoz, F. Maternal immunization: an update for pediatricians. Pediatric Annals 2013; 42: 153158.

Keywords

Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012

  • K. HUYGEN (a1), C. RODEGHIERO (a1), D. GOVAERTS (a2), I. LEROUX-ROELS (a3), P. MELIN (a4), M. REYNDERS (a5), S. VAN DER MEEREN (a6), S. VAN DEN WIJNGAERT (a7) and D. PIERARD (a6)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed